Search results for "Edema"

showing 10 items of 625 documents

Missense mutations in the coagulation factor XII (Hageman factor) gene in hereditary angioedema with normal C1 inhibitor.

2006

Hereditary angioedema is characterized by recurrent skin swelling, abdominal pain attacks, and potentially life-threatening upper airway obstruction. The two classic types are both caused by mutations within the complement C1 inhibitor gene. A recently described new type does not show a deficiency of C1 inhibitor and affects almost exclusively women. We screened twenty unrelated index patients with this new type of hereditary angioedema for mutations in the coagulation factor XII gene. Two different missense mutations were identified in exactly the same position within exon 9 of the F12 gene. 'Mutation 1' (1032C-->A), encountered in five patients, predicts a threonine-to-lysine substitution…

Malemedicine.medical_specialtyGenetic LinkageBiophysicsMutation MissenseCoagulation Factor XIImedicine.disease_causeBiochemistryC1-inhibitorInternal medicinemedicineMissense mutationHumansHereditary Angioedema Type IIIAngioedemaMolecular BiologyMutationFactor XIIAngioedemabiologyChemistryCell Biologymedicine.diseasePedigreeEndocrinologyHereditary angioedemaImmunologyFactor XIIbiology.proteinFemalemedicine.symptomComplement C1 Inhibitor ProteinBiochemical and biophysical research communications
researchProduct

Hereditary Angioedema with Normal C1 Inhibitor

2013

Until recently it was assumed that hereditary angioedema was a disease that results exclusively from a genetic deficiency of the C1 inhibitor. In 2000, families with hereditary angioedema, normal C1 inhibitor activity, and protein in plasma were described. Since then, numerous patients and families with that condition have been reported. Most of the patients were women. In many of the affected women, oral contraceptives, hormone replacement therapy containing estrogens, and pregnancies triggered the clinical symptoms. In some families mutations in the coagulation factor XII (Hageman factor) gene were detected.

Malemedicine.medical_specialtyImmunologyCoagulation Factor XIIC1-inhibitorDiagnosis DifferentialPregnancyRisk FactorsInternal medicinemedicineHumansImmunology and AllergyHereditary Angioedema Type IIIAngioedemaFactor XIIbiologyAngioedemabusiness.industryAngioedemas Hereditarymedicine.diseaseEndocrinologyTransgender hormone therapyFactor XIIMutationHereditary angioedemabiology.proteinFemaleDifferential diagnosismedicine.symptombusinessComplement C1 Inhibitor ProteinImmunology and Allergy Clinics of North America
researchProduct

Prediction of long-term major events soon after a first ST-segment elevation myocardial infarction by cardiovascular magnetic resonance.

2016

Cardiovascular magnetic resonance (CMR) predicts combined clinical events in post-ST-segment elevation myocardial infarction (STEMI) patients. However, its contribution to predicting long-term major events (ME: cardiac death and non-fatal myocardial infarction [MI]) is unknown. We aimed to assess whether CMR predicts long-term MEs when performed soon after STEMI.We prospectively recruited 546 STEMI patients between 2004 and 2012. The Left ventricular (LV) ejection fraction (LVEF,%), infarct size (IS), edema, hemorrhage, microvascular obstruction, and myocardial salvage were quantified by CMR at pre-discharge. During a mean follow-up of 840 days, 57 ME events (10%; 23 cardiac deaths, 34 non-…

Malemedicine.medical_specialtyMagnetic Resonance SpectroscopyMyocardial InfarctionHemorrhage030204 cardiovascular system & hematologyTime03 medical and health sciencesVentricular Dysfunction Left0302 clinical medicineEdemaInternal medicinemedicineST segmentEdemaHumansRadiology Nuclear Medicine and imagingcardiovascular diseases030212 general & internal medicineMyocardial infarctionProspective StudiesRegistriesEjection fractionmedicine.diagnostic_testClinical eventsbusiness.industryMyocardiumReproducibility of ResultsMagnetic resonance imagingGeneral MedicineMiddle AgedInfarct sizemedicine.diseaseMicrovesselscardiovascular systemCardiologyFemalemedicine.symptombusinessCardiac deathsFollow-Up StudiesEuropean journal of radiology
researchProduct

Long-term prognostic value of a comprehensive assessment of cardiac magnetic resonance indexes after an ST-segment elevation myocardial infarction.

2013

Abstract Introduction and objectives A variety of cardiac magnetic resonance indexes predict mid-term prognosis in ST-segment elevation myocardial infarction patients. The extent of transmural necrosis permits simple and accurate prediction of systolic recovery. However, its long-term prognostic value beyond a comprehensive clinical and cardiac magnetic resonance evaluation is unknown. We hypothesized that a simple semiquantitative assessment of the extent of transmural necrosis is the best resonance index to predict long-term outcome soon after a first ST-segment elevation myocardial infarction. Methods One week after a first ST-segment elevation myocardial infarction we carried out a comp…

Malemedicine.medical_specialtyNecrosisMagnetic Resonance SpectroscopyMyocardial InfarctionCoronary AngiographyElectrocardiographyNecrosisPredictive Value of TestsInternal medicineEdemamedicineST segmentHumansMyocardial infarctionAgedEjection fractionbusiness.industryHazard ratioGeneral MedicineMiddle Agedmedicine.diseasePrognosisTreatment OutcomeHeart failureCardiologyFemalemedicine.symptombusinessMaceFollow-Up StudiesRevista espanola de cardiologia (English ed.)
researchProduct

Color Doppler ultrasonography in pediatric intussusception.

1994

CDU was used in 11 children with intussusception. Demonstration of vascular images within the "pseudokidney" mass was possible in none of 11 cases. Of them, eight could be treated by hydrostatic reduction. In the remaining case, marked edema of the bowel wall did not allow reduction, and surgery had to be performed: no necrosis was observed in the surgical specimen. Both patients in whom CDU failed to demonstrate vascular signals had necrosis at surgery, and bowel resection was performed. Because of the limited number of patients examined at this time, no firm conclusions can be drawn from our experience. However, CDU seems a promising technique in detecting vascular changes occurring in in…

Malemedicine.medical_specialtyNecrosismedicine.medical_treatmentIntussusception (medical disorder)EdemamedicineColor doppler ultrasonographyHumansRadiology Nuclear Medicine and imagingUltrasonography Doppler ColorReduction (orthopedic surgery)Radiological and Ultrasound Technologybusiness.industryUltrasoundInfantInvaginationBowel resectionmedicine.diseaseSurgeryChild PreschoolFemaleRadiologymedicine.symptombusinessDigestive SystemIntussusceptionJournal of Ultrasound in Medicine
researchProduct

High-dose furosemide and small-volume hypertonic saline solution infusion for the treatment of leg edema in advanced cancer patients.

2008

Peripheral edema is a common feature in populations with advanced cancer, although it is seldom recognized. Diuretics are commonly employed and may show some benefit, but there are insufficient clinical trial data to draw useful conclusions about their clinical use. The aim of this prospective study was to evaluate the efficacy and tolerability of high-dose furosemide and small-volume hypertonic saline solution infusion in reducing leg edema in patients with advanced cancer treated unsuccessfully with diuretics. A prospective study was performed in a consecutive sample of 24 patients admitted to a pain relief and palliative care unit over a period of 18 months. To be eligible to enter the t…

Malemedicine.medical_specialtyPalliative caremedicine.medical_treatmentPeripheral edemaFurosemideEdemaNeoplasmsmedicineEdemaHumansLongitudinal StudiesProspective StudiesDiureticsInfusions IntravenousSalineGeneral NursingAgedAged 80 and overSaline Solution HypertonicLegbusiness.industryFurosemideMiddle AgedHypertonic salineSurgeryAnesthesiology and Pain MedicineTolerabilityAnesthesiaFemaleNeurology (clinical)medicine.symptomDiureticbusinessmedicine.drugJournal of pain and symptom management
researchProduct

Is it safe to exercise during oncological treatment? A study of adverse events during endurance and resistance training – data from the Phys-Can study

2020

Introduction Few studies have systematically evaluated the risk of adverse events (AEs) among persons exercising during oncological treatment. We aimed to describe incidence and types of AEs during exercise for persons undergoing oncological treatment, and associations to exercise intensity, exercise adherence, chemotherapy treatment, initial aerobic fitness. A second aim was to compare incidence of lymphedema, periphery inserted central catheter (PICC) complications, and other new medical conditions (any illness or injury occurred during the exercise trial) between high-intensity vs low-to-moderate exercise and usual care (UC). Methods This descriptive, comparative study was based on data …

Malemedicine.medical_specialtyPhysical exercise030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicineHumansMedicineAerobic exerciseRadiology Nuclear Medicine and imagingAdverse effectExercisebusiness.industryIncidence (epidemiology)Medical recordResistance TrainingHematologyGeneral Medicinemedicine.diseaseExercise TherapyLymphedemaOncologyPhysical Fitness030220 oncology & carcinogenesisQuality of LifePhysical therapyExercise intensityObservational studybusinessActa Oncologica
researchProduct

Prophylaxis of Pseudophakic Cystoid Macular Edema with Intraoperative Pegaptanib

2011

The purpose of this study was to determine the efficacy of an intraoperative intravitreal pegaptanib injection during phacoemulsification in preventing the development of pseudophakic cystoid macular edema (CME) following cataract surgery.This prospective, controlled pilot study was carried out at the Department of Ophthalmology, Nuevo Hospital Universitario y Politécnico La Fe, Valencia (Spain). Five hundred patients with cataract and healthy retina were included in the study. Patients were assigned in a 1:1 ratio to receive an intraoperative intravitreal pegaptanib injection (n=250) or not (control group, n=250) associated with standardized phacoemulsification surgery and postoperative tr…

Malemedicine.medical_specialtyPseudophakiagenetic structuresPegaptanibmedicine.medical_treatmentPilot ProjectsMacular EdemaHospitals UniversityPostoperative treatmentOphthalmologymedicineHumansPharmacology (medical)Prospective StudiesMacular edemaAgedAged 80 and overPharmacologyPhacoemulsificationSurgical complicationbusiness.industryIncidence (epidemiology)Outcome measuresPhacoemulsificationAptamers NucleotideCataract surgerymedicine.diseaseeye diseasesSurgeryOphthalmologyTreatment OutcomeSpainIntravitreal InjectionsFemalesense organsbusinessTomography Optical CoherenceFollow-Up Studiesmedicine.drugJournal of Ocular Pharmacology and Therapeutics
researchProduct

A strange pneumonia

2013

We report the case of a 62-year-old man with non-ST elevation myocardial infarction complicated by partial rupture of the antero-lateral papillary muscle in which severe mitral regurgitation with lateralized direction towards the right pulmonary veins gave unilateral pulmonary oedema, resembling an acute pneumonia.Unilateral pulmonary oedema is a rare entity, more frequently appearing as opacity of the right lung and always associated with severe mitral regurgitation. It is very important to suspect and promptly recognize unilateral pulmonary oedema because initial misdiagnosis leads to a delay in the initiation of appropriate treatment and to an increased risk of mortality.

Malemedicine.medical_specialtyPulmonary Edema030204 cardiovascular system & hematologyPulmonary oedemaDiagnosis Differential03 medical and health sciences0302 clinical medicineInternal medicinemedicineHumanspneumoniaMyocardial infarctionNon-ST Elevated Myocardial InfarctionPapillary muscleMitral regurgitationLungbusiness.industryRare entityGeneral MedicineMiddle Agedmedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareMyocardial infarctionPneumoniamedicine.anatomical_structureIncreased risk030228 respiratory systemCardiologyCardiology and Cardiovascular MedicinebusinessJournal of Cardiovascular Medicine
researchProduct

Local safety of repeated intravitreal Ozurdex

2013

Sir, The article entitled ‘Twelve-month experience with Ozurdex for the treatment of macular edema associated with retinal vein occlusion'1 highlights the significant cataract progression in eyes receiving more than one Ozurdex implant. We retrospectively reviewed the charts of all patients with macular edema secondary to retinal vein occlusion (RVO) refractory to current therapies and treated with Ozurdex from April 2010 until March 2012. The mean age of patients with branch RVO (n=33) was 72.4. In eyes receiving a second Ozurdex implant, four out of the five phakic eyes showed progression of cataract requiring surgery. We registered one case of anterior chamber migration resulting in a bu…

Malemedicine.medical_specialtyRetinal Veingenetic structuresDexamethasoneMacular EdemaRefractoryOphthalmologyCorrespondenceRetinal Vein OcclusionOcclusionmedicineHumansIn patientGlucocorticoidsMacular edemaDexamethasonebusiness.industryIncidence (epidemiology)medicine.diseaseeye diseasesSurgeryOphthalmologyFemalesense organsImplantbusinessmedicine.drugEye
researchProduct